148
Participants
Start Date
September 15, 2022
Primary Completion Date
February 24, 2025
Study Completion Date
February 24, 2025
Open Label Extension Study
This study will investigate the safety and efficacy of extended treatments for the management of symptoms related to PD.
Riverside Neurology Specialists, Newport News
Meridian Clinical Research, Raleigh
Medical University of South Carolina, Charleston
Headlands Research Orlando, Orlando
Parkinson's Disease and Movement Disorder of Boca Raton, Boca Raton
University of South Florida, Tampa
Veracity Neuroscience, Memphis
Cleveland Clinic, Cleveland
Quest Research, Farmington Hills
Mercy Health Saint Mary's, Grand Rapids
University of Kansas Medical Center - Parkinson's Disease Center, Kansas City
Houston Methodist Neurological Institute, Houston
Movement Disorder Center of Arizona, Scottsdale
University of New Mexico, Albuquerque
Cedars-Sinai Medical Center, Los Angeles
Lead Sponsor
Scion NeuroStim
INDUSTRY